Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $16.57 USD
Change Today -1.45 / -8.05%
Volume 1.5M
IMGN On Other Exchanges
Symbol
Exchange
Frankfurt
As of 3:47 PM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - IMMUNOGEN INC (IMGN)

ImmunoGen, Inc. to Report Q4, 2015 on Jul 31, 2015
CapIQ 07/31/2015 12:00 PM ET
ImmunoGen, Inc. to Report Q3, 2015 on Apr 24, 2015
CapIQ 07/31/2015 12:00 PM ET
ImmunoGen, Inc. to Report Q2, 2015 on Jan 30, 2015
CapIQ 07/31/2015 12:00 PM ET

2014 revenues at ImmunoGen, Inc. totaled $59.9M USD, while annual losses equaled $0.83 per share.

Quarterly Earnings & Estimates - IMMUNOGEN INC (IMGN)

Actuals vs. Estimates for IMMUNOGEN INC IMGN

ImmunoGen, Inc.'s Quarterly Earnings

ImmunoGen, Inc. reported 4th quarter 2014 losses of $0.31 per share on 08/3/2014.

Annual Earnings & Estimates - IMMUNOGEN INC (IMGN)

Actuals vs. Estimates for IMMUNOGEN INC IMGN

ImmunoGen, Inc.'s Annual Earnings

ImmunoGen, Inc. reported annual 2014 losses of $0.83 per share on 08/3/2014.

Quarterly Revenues - IMMUNOGEN INC (IMGN)

Actuals vs. Estimates for IMMUNOGEN INC IMGN

ImmunoGen, Inc.'s Quarterly Revenues

ImmunoGen, Inc. had 4th quarter 2014 revenues of $5.7M USD. This missed the $10.0M USD consensus estimate of the 12 analysts following the company. This was 49.9% above the prior year's 4th quarter results.

Annual Revenues - IMMUNOGEN INC (IMGN)

Actuals vs. Estimates for IMMUNOGEN INC IMGN

ImmunoGen, Inc.'s Annual Revenues

ImmunoGen, Inc. had revenues for the full year 2014 of $59.9M USD. This was 68.6% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMGN:US $16.58 USD -1.44

IMGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ablynx NV €13.50 EUR +0.18
Abzena PLC 81.00 GBp 0.00
BioInvent International AB kr2.65 SEK +0.01
Kyowa Hakko Kirin Co Ltd ¥2,051 JPY +33.00
MorphoSys AG €73.55 EUR +0.65
View Industry Companies
 

Industry Analysis

IMGN

Industry Average

Valuation IMGN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 18.3x
Price/Book 44.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 14.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUNOGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.